Asia Pacific Cell and Gene Therapy Manufacturing Services Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Regional Analysis

6.2 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Revenue 2020-2030 (US$ Million)

6.3 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Forecast Analysis

7. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Analysis – by Type

7.1 Cell Therapy

7.1.1 Overview
7.1.2 Cell Therapy: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Gene Therapy

7.2.1 Overview
7.2.2 Gene Therapy: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Analysis – by Indication

8.1 Cancer

8.1.1 Overview
8.1.2 Cancer: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Orthopedics

8.2.1 Overview
8.2.2 Orthopedics: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Analysis – by Application

9.1 Clinical Manufacturing

9.1.1 Overview
9.1.2 Clinical Manufacturing: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Commercial Manufacturing

9.2.1 Overview
9.2.2 Commercial Manufacturing: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Analysis – by End User

10.1 Pharmaceutical and Biotechnology Companies

10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Contract Research Organization

10.2.1 Overview
10.2.2 Contract Research Organization: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 China: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.1.2 China: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.1.3 China: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.1.4 China: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.2 India: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 India: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.2.2 India: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.2.3 India: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.2.4 India: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.3 Japan: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 Japan: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.3.2 Japan: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.3.3 Japan: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.3.4 Japan: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.4 Australia: Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Australia: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.4.2 Australia: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.4.3 Australia: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.4.4 Australia: Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.5 Rest of Asia-Pacific : Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Catalent Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Charles River Laboratories International Inc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 FUJIFILM Holdings Corp

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Lonza Group AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Merck KgaA

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Nikon Corp

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Takara Bio Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Thermo Fisher Scientific Inc

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 WuXi AppTec Co Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Cell and Gene Therapy Manufacturing Services Market